These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
411 related items for PubMed ID: 19655698
1. Finasteride treatment and neuroactive steroid formation. Dusková M, Hill M, Hanus M, Matousková M, Stárka L. Prague Med Rep; 2009; 110(3):222-30. PubMed ID: 19655698 [Abstract] [Full Text] [Related]
3. The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment. Hill M, Petrik R, Hampl R, Stárka L. Horm Metab Res; 1996 Oct; 28(10):562-4. PubMed ID: 8934217 [Abstract] [Full Text] [Related]
5. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J. J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374 [Abstract] [Full Text] [Related]
6. The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial. Matsumoto AM, Tenover L, McClung M, Mobley D, Geller J, Sullivan M, Grayhack J, Wessells H, Kadmon D, Flanagan M, Zhang GK, Schmidt J, Taylor AM, Lee M, Waldstreicher J, Pless Study Group. J Urol; 2002 May; 167(5):2105-8. PubMed ID: 11956450 [Abstract] [Full Text] [Related]
7. [The long-term treatment of patients with benign prostatic hyperplasia using Proscar]. Lopatkin NA, Roilans PJ, Stoner E. Urol Nefrol (Mosk); 1996 May; (1):2-4. PubMed ID: 8659035 [Abstract] [Full Text] [Related]
8. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study. Anwarul Islam AK, Kashem MA, Shameem IA, Kibria SA. Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):54-61. PubMed ID: 16967810 [Abstract] [Full Text] [Related]
10. Finasteride: the first 5 alpha-reductase inhibitor. Sudduth SL, Koronkowski MJ. Pharmacotherapy; 1993 Aug; 13(4):309-25; discussion 325-9. PubMed ID: 7689728 [Abstract] [Full Text] [Related]
11. The anxiolytic effect of pregnancy in rats is reversed by finasteride. de Brito Faturi C, Teixeira-Silva F, Leite JR. Pharmacol Biochem Behav; 2006 Nov; 85(3):569-74. PubMed ID: 17156832 [Abstract] [Full Text] [Related]
16. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction. Rittmaster RS. Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794 [Abstract] [Full Text] [Related]
17. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old. Camacho FM, García-Hernández MJ, Fernández-Crehuet JL. Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752 [Abstract] [Full Text] [Related]
19. A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits. Montorsi F, Alcaraz A, Desgrandchamps F, Hammerer P, Schröder F, Castro R. Prostate; 2009 Jun 01; 69(8):895-907. PubMed ID: 19267353 [Abstract] [Full Text] [Related]